Topical Ocular Delivery to Laser-Induced Choroidal Neovascularization by Dual Internalizing RGD and TAT Peptide-Modified Nanoparticles [Corrigendum]

Chu YC, Chen N, Yu HJ, et al. Int J Nanomedicine. 2017;12:1353–1368. The authors have advised due to an error that occurred inadvertently at the time of figure assembly, Figures 5 and 6 on pages 1362 and 1363, respectively, are inorrect. The correct figures are as follows. Figure 5 Fluorescence microscopy images of the cellular uptake of NPs with 5, 20, and 40% TAT–PEG –PLGA in HUVECs.Abbreviations: HUVECs, human umbilical vein endothelial cells; iRGD, internalizing arginine-glycine-aspartic acid; NP, nanoparticle; PEG, poly(ethylene glycol); PLGA, poly(lactic-co-glycolic acid); TAT, transactivated transcription.Notes: iRGD–5% TAT-Nile red-NP, iRGD and TAT dual-modified NPs labeled with Nile red with 5% TAT–PEG–PLGA; iRGD–20% TAT-Nile red-NP, iRGD and TAT dual-modified NPs labeled with Nile red with 20% TAT–PEG–PLGA; iRGD–40% TAT-Nile red-NP, iRGD and TAT dual-modified NPs labeled with Nile red with 40% TAT–PEG –PLGA. Figure 6 Cellular uptake images for different NPs after treating HUVECs at 1, 3, and 6 h.Abbreviations: HUVECs, human umbilical vein endothelial cells; iRGD, internalizing arginine-glycine-aspartic acid; mPEG, methoxy-poly(ethylene glycol); NP, nanoparticle; PLGA, poly(lactic-co-glycolic acid); TAT, transactivated transcription.Notes: The blue fluorescence and the red fluorescence belong to Hoechst 33342 and NPs labeled with Nile red, respectively. mPEG–PLGA-Nile red-NP, mPEG–PLGA NPs labeled with Nile red; iRGD-Nile red-NP, iRGD-modified NPs labeled with Nile red; TAT-Nile red-NP, TAT-modified NPs labeled with Nile red; iRGD–TAT-Nile red-NP, iRGD and TAT dual-modified NPs labeled with Nile red. The authors apologize for the errors and advise they do not affect the results and conclusions of the paper.